PrecisionLife

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that could be faster to recruit and more likely to succeed 4 December 2025 -- Oxford, UK -- PrecisionLife today announced new findings from the most detailed genetic analysis of myalgic encephalomyelitis...

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that could be faster to recruit and more likely to succeed 4 December 2025 -- Oxford, UK -- PrecisionLife today announced new findings from the most detailed genetic analysis of myalgic encephalomyelitis...

PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study

MetX funded by $1M grant from Metrodora Foundation to accelerate research for complex multisystem disorders 18 September 2024 -- Utah, US, and Oxford, UK -- PrecisionLife, a leading clinical-stage precision medicine company focused on chronic diseases, and Metrodora Institute, an advanced US research and healthcare center, have begun sharing the first research results with participants...

PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long-COVID-19 Patients

Up to 1,000 patients being recruited into targeting precision medicine clinical trials expected to readout results as early as this year Trials are designed to provide validation of safety and effectiveness for novel diagnostics and innovative clinical care pathways in ME/CFS and Long-COVID-19. 14 May 2024 -- Utah, US, and Oxford, UK -- The leading...
8b Bankside Hanborough Business Park Oxford, OX29 8LJ

+44 (0)1865 575170